Article
Sex-dependent Schizophrenia and Drug Reward Behavioral Phenotypes in Metabotropic Glutamate 5 Receptor Heterozygous and Homozygous Mice.
Schizophrenia bulletin - 3 Jul 2026
Rosa Porto Rossana, Kreilaus Fabian, Hannan Anthony J, Chesworth Rose, Karl Tim
Abstract excerpt
BACKGROUND AND HYPOTHESIS: The metabotropic glutamate 5 (mGlu5) receptor is a potential therapeutic target for psychiatric disorders, including schizophrenia and substance use disorders. Indeed, mGlu5 is expressed in forebrain regions (eg, striatum, prefrontal cortex), and mGlu5 modulates N-methyl-D-aspartate receptor function and second messenger signaling. Also, male mice lacking mGlu5 display...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
